Adult acute lymphocytic leukemia. Introduction and questions related to current programs

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Significant progress has been made during the past 30 years in understanding the biology of adult acute lymphocytic leukemia and in treating the disease. This article lists some of the questions related to the current treatment programs for ALL and notes the remaining articles in this issue that address those questions.

Original languageEnglish (US)
Pages (from-to)1205-1208
Number of pages4
JournalHematology/Oncology Clinics of North America
Volume14
Issue number6
DOIs
StatePublished - Jan 1 2000

Fingerprint

Precursor Cell Lymphoblastic Leukemia-Lymphoma

ASJC Scopus subject areas

  • Hematology
  • Oncology

Cite this

Adult acute lymphocytic leukemia. Introduction and questions related to current programs. / Kantarjian, Hagop M.

In: Hematology/Oncology Clinics of North America, Vol. 14, No. 6, 01.01.2000, p. 1205-1208.

Research output: Contribution to journalArticle

@article{02464c4a23bd44d1b2b33b648bb62ec5,
title = "Adult acute lymphocytic leukemia. Introduction and questions related to current programs",
abstract = "Significant progress has been made during the past 30 years in understanding the biology of adult acute lymphocytic leukemia and in treating the disease. This article lists some of the questions related to the current treatment programs for ALL and notes the remaining articles in this issue that address those questions.",
author = "Kantarjian, {Hagop M}",
year = "2000",
month = "1",
day = "1",
doi = "10.1016/S0889-8588(05)70182-9",
language = "English (US)",
volume = "14",
pages = "1205--1208",
journal = "Hematology/Oncology Clinics of North America",
issn = "0889-8588",
publisher = "W.B. Saunders Ltd",
number = "6",

}

TY - JOUR

T1 - Adult acute lymphocytic leukemia. Introduction and questions related to current programs

AU - Kantarjian, Hagop M

PY - 2000/1/1

Y1 - 2000/1/1

N2 - Significant progress has been made during the past 30 years in understanding the biology of adult acute lymphocytic leukemia and in treating the disease. This article lists some of the questions related to the current treatment programs for ALL and notes the remaining articles in this issue that address those questions.

AB - Significant progress has been made during the past 30 years in understanding the biology of adult acute lymphocytic leukemia and in treating the disease. This article lists some of the questions related to the current treatment programs for ALL and notes the remaining articles in this issue that address those questions.

UR - http://www.scopus.com/inward/record.url?scp=0033634907&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0033634907&partnerID=8YFLogxK

U2 - 10.1016/S0889-8588(05)70182-9

DO - 10.1016/S0889-8588(05)70182-9

M3 - Article

C2 - 11147219

AN - SCOPUS:0033634907

VL - 14

SP - 1205

EP - 1208

JO - Hematology/Oncology Clinics of North America

JF - Hematology/Oncology Clinics of North America

SN - 0889-8588

IS - 6

ER -